Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.

Biospecimen Repository and Histopathology Service


HomeClinical Trial Laboratory (CTL)Banking Group | Histopathology Service (HPS) | EquipmentRecent Enhancements | Request De-Identified Biospecimens


Interim Director: Parisa Javidian, MD

Associate Director: Hatem E. Sabaawy, MD, PhD

Manager: Kelly Walton

Biospecimen Repository and Histopathology Service 



The Biospecimen Repository and Histopathology Service shared resource (Biorepository) of the Rutgers Cancer Institute of New Jersey is a Cancer Center managed shared resource whose purpose is to support transdisciplinary and translational research through cost-effective, quality controlled tissue collection, biospecimen procurement and processing and cancer clinical trial support.

CAP accreditationThe Biorepository provides tissues for cancer research through a seamless acquisition-processing-distribution pathway. The resource staff also provides collection, processing and shipping for thousands of clinical trial specimens by adhering to specific protocols. Our CLIA licensed histology laboratory delivers state of the art technologies for tissue analysis along with professional tissue examination by board-certified pathologists. The Biorepository follows best practices as dictated by the College of American Pathologists (CAP) guidelines.

Biospecimen Repository and Histopathology TeamThe Biorepository uses state of the art technologies for tissue analysis and professional interpretation under CAP guidelines. In addition, the Biorepository serves as an “honest broker” and maintains the chain of custody for patient samples and their clinical annotations.


The Biorepository is comprised of three divisions:

The Biorepository Lab Divisions support clinical trials, tissue banking and basic science by collecting, cataloging, processing, storing and distributing bio-specimens from human subjects while archiving useful medical information along with written patient consents. Each of the divisions is distinct, yet they cooperate to provide a seamless workflow and unparalleled service, and are operated by highly qualified technologists and strong leadership.



"Services, results and/or products in support of the research project were generated by the Rutgers Cancer Institute of New Jersey Biospecimen Repository and Histopathology Service Shared Resource, supported, in part, with funding from NCI-CCSG P30CA072720-5919."

Please consider including the names of individuals from the shared resource if they provided any intellectual input or additional effort.

NIH Public Access Policy: Publications that result from services provided by this Shared Resource must be compliant with the NIH Public Access policy by submitting your paper to PubMed Central. Go to: for PubMed Central's submission methods instructions.  

If you require additional guidance on how to properly acknowledge a single shared resource or multiple shared resources you may contact Janet Bandoy, Shared Resources Coordinator.


Last updated 06/09/2020